ARTICLE | Clinical News
VAX2012Q: Phase II started
June 22, 2015 7:00 AM UTC
VaxInnate began a double-blind, U.S. Phase II trial to compare a single dose of 8 and 12 ug VAX2012Q vs. Fluzone Quadrivalent from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) in up to 450 healthy...